Patents by Inventor Parmjit Jat

Parmjit Jat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMORTALIZATION OF MAMMALIAN CELLS
    Publication number: 20090252715
    Abstract: Genomic instability in T antigen expressing cells can be overcome by modifying the gene expressing T antigen so that it lacks Bub1 binding. Stable cell lines can be produced by incorporation of the modified T antigen gene, preferably together with the catalytic sub-unit of the telomerase construct.
    Type: Application
    Filed: June 10, 2009
    Publication date: October 8, 2009
    Inventors: THOMAS ROBERTS, Ole Gjoerup, Parmjit Jat, Marina Cotsiki
  • Immortalization of Mammalian Cells
    Publication number: 20070274969
    Abstract: Genomic instability in T-antigen expressing cells can be overcome by modifying the gene expressing T-antigen so that it lacks Bub1 binding. Stable cell lines can be produced by incorporation of the modified T-antigen gene, preferably together with the catalytic sub-unit of the telomerase construct.
    Type: Application
    Filed: September 10, 2004
    Publication date: November 29, 2007
    Inventors: Thomas Roberts, Ole Gjoerup, Parmjit Jat, Marina Cotsiki
  • Conditional immortalization of cells
    Patent number: 6399384
    Abstract: A recombinant, or genetically engineered, mammalian cell, comprises a conditionally-inducible oncogene and an exogenous polynucleotide encoding the catalytic sub-unit of the telomerase complex. The recombinant cells are useful in therapy, to replace lost or damaged cells.
    Type: Grant
    Filed: September 15, 2000
    Date of Patent: June 4, 2002
    Assignees: Reneuron Limited, Ludwig Institute for Cancer Research
    Inventor: Parmjit Jat